The effect of metformin treatment on CRBP-I Level and cancer development in the liver of HBx transgenic mice

Korean Journal of Physiology and Pharmacology

Volumn 17, Issue 5, 2013, Pages 455-461

  Kim, Jo Heon ^a   Alam, Md Morshedul ^b   Park, Doek Bae ^b   Cho, Moonjae ^b   Lee, Seung Hong ^c   Jeon, You Jin ^d   Yu, Dae Yeul ^e   Kim, Tae Du ^f   Kim, Ha Young ^g   Cho, Chung Gu ^g   Lee, Dae Ho ^g  

^a Chonnam National University Medical School   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

^c Konkuk University   (South Korea)

^d Jeju National University   (South Korea)

^e Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^f Dongsuncheon Clinic   (South Korea)

^g Wonkwang University School of Medicine   (South Korea)

Author keywords

Cellular retinol binding protein I; HBx protein; Hepatocellular carcinoma; Metformin; Retinoids

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN 1; CYTOCHROME P450 26A1; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; GLUCOSE; HEPATITIS B VIRUS X PROTEIN; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE B; RETINOIC ACID; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID DIET; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HISTOLOGY; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WHITE ADIPOSE TISSUE;

EID: 84888624970     PISSN: 12264512     EISSN: 20933827     Source Type: Journal    
DOI: 10.4196/kjpp.2013.17.5.455     Document Type: Article

References (38)

1. Custro N, Carroccio A, Ganci A, Scafidi V, Campagna P, Di Prima L, Montalto G. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab. 2001;27:476-481.
2. Shin HJ, Park YH, Kim SU, Moon HB, Park do S, Han YH, Lee CH, Lee DS, Song IS, Lee DH, Kim M, Kim NS, Kim DG, Kim JM, Kim SK, Kim YN, Kim SS, Choi CS, Kim YB, Yu DY. Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase. J Biol Chem. 2011;286:29872-29881.
3. Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology. 2007;132:1955-1967.
4. Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol. 2011; 26 Suppl 1:144-152.
5. Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol. 1999; 31:123-132.
6. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology. 2010;51:1820-1832.
7. Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov. 2007;6:793-810.
8. Kluwe J, Wongsiriroj N, Troeger JS, Gwak GY, Dapito DH, Pradere JP, Jiang H, Siddiqi M, Piantedosi R, O'Byrne SM, Blaner WS, Schwabe RF. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut. 2011;60:1260-1268.
9. Yoon JS, Lee MY, Lee JS, Park CS, Youn HJ, Lee JH. Bis is involved in glial differentiation of p19 cells induced by retinoic Acid. Korean J Physiol Pharmacol. 2009;13:251-256.
10. Duong V, Rochette-Egly C. The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochim Biophys Acta. 2011;1812:1023-1031.
11. Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem J. 2000;348 Pt 3:481-495.
12. Zizola CF, Frey SK, Jitngarmkusol S, Kadereit B, Yan N, Vogel S. Cellular retinol-binding protein type I (CRBP-I) regulates adipogenesis. Mol Cell Biol. 2010;30:3412-3420.
13. Ashla AA, Hoshikawa Y, Tsuchiya H, Hashiguchi K, Enjoji M, Nakamuta M, Taketomi A, Maehara Y, Shomori K, Kurimasa A, Hisatome I, Ito H, Shiota G. Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease. Hepatol Res. 2010;40:594-604.
14. Bonet ML, Ribot J, Palou A. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim Biophys Acta. 2012;1821:177-189.
15. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J, Hamilton JA, Tang G, Dolnikowski GG, Vogel S, Duester G, Plutzky J. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med. 2007;13:695-702.
16. Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, Wu MS, Lin JH, Wu CY. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut. 2013;62:606-615.
17. Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for liver cancer prevention in patients with type 2 diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:2347-2353.
18. Kang W, Hong HJ, Guan J, Kim DG, Yang EJ, Koh G, Park D, Han CH, Lee YJ, Lee DH. Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism. 2012;61:424-433.
19. Ribaya-Mercado JD, Holmgren SC, Fox JG, Russell RM. Dietary beta-carotene absorption and metabolism in ferrets and rats. J Nutr. 1989;119:665-668.
20. Green MH, Snyder RW, Akohoue SA, Green JB. Increased rat mammary tissue vitamin A associated with increased vitamin A intake during lactation is maintained after lactation. J Nutr. 2001;131:1544-1547.
21. Tang GW, Russell RM. 13-cis-retinoic acid is an endogenous compound in human serum. J Lipid Res. 1990;31:175-182.
22. Berry DC, Noy N. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferationactivated receptor beta/delta and retinoic acid receptor. Mol Cell Biol. 2009;29:3286-3296.
23. Muto Y, Omori M. A novel cellular retinoid-binding protein, F-type, in hepatocellular carcinoma. Ann N Y Acad Sci. 1981; 359:91-103.
24. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem. 1999;274:23695-23698.
25. Jing Y, Waxman S, Mira-y-Lopez R. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells. Cancer Res. 1997;57:1668-1672.
26. Theodosiou M, Laudet V, Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci. 2010;67:1423-1445.
27. Sporn MB, Squire RA, Brown CC, Smith JM, Wenk ML, Springer S. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. Science. 1977;195:487-489.
28. Hill DL, Grubbs CJ. Retinoids and cancer prevention. Annu Rev Nutr. 1992;12:161-181.
29. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med. 1996;334:1561-1567.
30. Sauvant P, Cansell M, Atgie C. Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes. J Physiol Biochem. 2011;67:487-496.
31. O'Byrne SM, Wongsiriroj N, Libien J, Vogel S, Goldberg IJ, Baehr W, Palczewski K, Blaner WS. Retinoid absorption and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). J Biol Chem. 2005;280:35647-35657.
32. Liu L, Gudas LJ. Disruption of the lecithin:retinol acyltransferase gene makes mice more susceptible to vitamin A deficiency. J Biol Chem. 2005;280:40226-40234.
33. McCormick DL, Hollister JL, Bagg BJ, Long RE. Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides. Carcinogenesis. 1990;11:1605-1609.
34. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126:460-468.
35. Muto Y, Omori M, Sugawara K. Demonstration of a novel cellular retinol-binding protein, F-type, in hepatocellular carcinoma. Gann. 1979;70:215-222.
36. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta. 1999; 1440:139-162.
37. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 2007; 129:723-733.
38. Tatsukawa H, Sano T, Fukaya Y, Ishibashi N, Watanabe M, Okuno M, Moriwaki H, Kojima S. Dual induction of caspase 3-and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells. Mol Cancer. 2011;10:4.